Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Clinical study on treatment of children attention deficit hyperactivity disorder by Jiangqian Granule

Abstract

Objective

To explore the effect of Jiangqian granule (JQG) in treating children attention deficit hyperactivity disorder (ADHD) and its mechanism.

Methods

Eighty children with ADHD were randomly divided into two groups, the treated group treated with JQG and the control group treated with Ritalin. Blood lead concentration and Conners scoring were measured before and after 3 months treatment and the therapeutic effects were assessed. Besides, blood lead concentration and Conners scoring in 60 healthy children were also determined for control.

Results

The total effective rate in the treated group and the control group was 92.5% and 72.5% respectively, significant difference existed between the two groups. Blood lead level and Conners scores in ADHD patients were significantly higher than those in the healthy control (P<0.01). The two parameters decreased after treatment in both groups, but the lowering was more significant in the treated group (P<0.05,P <0.01).

Conclusion

Blood lead concentration raised in ADHD patients, JQG could enhance the clinical therapeutic effect by means of reducing the blood lead.

This is a preview of subscription content, log in to check access.

Author information

Correspondence to Jian Chen or Yu-yan Chen or Xiao-ming Wang or Gui-qi Xuan.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chen, J., Chen, Y., Wang, X. et al. Clinical study on treatment of children attention deficit hyperactivity disorder by Jiangqian Granule. CJIM 8, 99 (2002). https://doi.org/10.1007/BF02934431

Download citation

Keywords

  • Attention Deficit Hyperactivity Disorder
  • Liver Fibrosis
  • Ritalin
  • Attention Deficit Hyperactivity Disorder
  • Blood Lead Level